Abdallah Ibrahim AbuJlambo

Dr. Abdallah Ibrahim AbuJlambo

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

22 May 2026 in Scientific Reports
Verified
Journal Article
Open access
AAAbdallah Ibrahim AbuJlambo
Abdallah Ibrahim AbuJlambo
MAMaha AbuZarifa
Maha AbuZarifa
YAYara Ashour
Yara Ashour
HLHanne Lossius
Hanne Lossius
GVGuido Veronese
Guido Veronese
This cross-sectional study examined chronic pain, mental health, and pain catastrophizing among 272 Palestinian patients at Al-Shifa Hospital in Gaza. Participants (median age 43; 57.7% female) completed assessments using the depression, anxiety, and stress (DASS-21) and pain catastrophizing (PCS) scales. Most were married (78.7%), unemployed (50%), and lived on <1,974 ILS/month (94.1%). Lower limb pain (26.8% knee) predominated, with a median pain duration of 4 years. High rates of mental health symptoms were observed: depression (83.1%), anxiety (83.8%), and stress (88.6%), with 56.3% showing extremely severe anxiety. Pain catastrophizing correlated strongly with psychological distress. Findings highlight the need for integrated, trauma-informed pain management addressing both biomedical and psychosocial factors in conflict-affected populations. Future research should explore how sociopolitical stressors and catastrophic thinking interact to exacerbate pain experiences in humanitarian crises.

27 April 2026 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
GIGabriel Ind
Gabriel Ind
ZHZain Hashmi
Zain Hashmi
SAShivansh Ahuja
Shivansh Ahuja
TFTamara Fayad
Tamara Fayad
ZKZaneh Kahook
Zaneh Kahook
AAAbdallah Ibrahim AbuJlambo
Abdallah Ibrahim AbuJlambo
Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein-associated disease (MOGAD) are the major types of demyelinating disorders of the central nervous system (CNS). Demyelinating disorders impact women disproportionately and frequently present during reproductive years. These conditions can cause significant neurological disability and psychosocial challenges, especially for women. Because they often present during reproductive years, clinicians frequently manage contraception, pregnancy, and the postpartum period alongside disease control. Sex-specific evidence, therefore, becomes especially important for treatment decisions. Despite this, sex-specific differences in epidemiology, immunopathology, clinical features, and therapeutic response remain inconsistently addressed in both clinical practice and research. In this review, we synthesize current evidence on the factors underlying the female predominance observed in MS, NMOSD, and MOGAD, and discuss the clinical consequences of these findings. We investigate the influence of sex hormones, X-chromosome–mediated immune regulation, and immunological changes associated with pregnancy and the postpartum period, as well as disease-specific mechanisms. We also examine how these factors affect diagnosis, prognosis, therapeutic decision-making, pregnancy management, and quality of life. Finally, we highlight important gaps in knowledge and underscore the necessity for a sex-informed approach to the diagnosis, management, and research of autoimmune demyelinating diseases.

6 July 2026 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
PDF file
AAAbdallah Ibrahim AbuJlambo
Abdallah Ibrahim AbuJlambo
MAMaha AbuZarifa
Maha AbuZarifa
RSRejean R. R. Sawh
Rejean R. R. Sawh
SNSubhash Reddy Narayana Reddy N
Subhash Reddy Narayana Reddy N
MSMuhammad Bin Salman
Muhammad Bin Salman
HAHazem Ayesh
Hazem Ayesh
Background: Diabetic ketoacidosis (DKA) is a life‐threatening metabolic emergency requiring prompt insulin therapy. Although intravenous (IV) insulin infusion remains the standard treatment, early initiation of subcutaneous (SC) basal insulin during IV therapy may improve outcomes. We evaluated the efficacy and safety of early basal insulin administration in adults with DKA. Methods: A systematic review and meta‐analysis following PRISMA 2020 guidelines searched PubMed, Embase and Cochrane Library from inception to February 2026 for randomised controlled trials (RCTs) comparing early SC basal insulin plus IV insulin versus IV insulin alone in adults with DKA. Primary outcomes were time to DKA resolution and hospital length of stay. Secondary outcomes included total fluid requirement, hypoglycaemia, rebound hyperglycaemia, recurrent DKA, electrolyte disturbances and mortality. Meta‐regression explored sources of heterogeneity. Results: Eight RCTs involving 407 participants were included. Early basal insulin significantly reduced time to DKA resolution (MD −4.06 h, 95% CI −5.53 to −2.58; p < 0.0001; I 2 = 56.3%), with consistent findings in sensitivity analysis (MD −3.44 h; I 2 = 0%). Total fluid requirements decreased by approximately 400 mL, although clinical significance was modest. No significant differences were observed in hospital length of stay, rebound hyperglycaemia, recurrent DKA, hypoglycaemia, hypokalaemia, or mortality. Meta‐regression showed no significant effect modification by age, BMI, sample size, or male proportion. Conclusions: Early SC basal insulin combined with IV insulin significantly shortens DKA resolution time and modestly reduces fluid requirements without increasing adverse events. While no significant effects were observed on hospital stay or recurrence outcomes, these findings support the safety and potential clinical benefit of early basal insulin use in DKA management. Larger multicentre trials are warranted.

14 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AAAbdallah Ibrahim AbuJlambo
Abdallah Ibrahim AbuJlambo
MKMuhammad Ali Khan
Muhammad Ali Khan
HHHiba Hamdar
Hiba Hamdar
BJBassam G. Abu Jawdeh
Bassam G. Abu Jawdeh
Background: Acute tubulointerstitial nephritis (ATIN) is a significant yet under-monitored cause of U.S. mortality, particularly among the elderly. This study anrackalyzed national trends and demographic disparities in age-adjusted mortality rates (AAMRs) from 1999 to 2020 to identify high-risk populations and inform public health policy. Methods: Using the CDC WONDER database, we conducted a retrospective analysis of 6872 ATIN-related deaths. AAMRs (per 100,000) were stratified by sex, race, and census region. Temporal shifts were quantified using Joinpoint regression to determine annual percentage changes (APC) and 95% confidence intervals (CIs). Results: The analysis revealed a distinct “V-shaped” mortality trend across the 22-year period. Following an initial decline from 1999 to 2013, AAMRs rose sharply through 2020. Males experienced a slightly steeper recent increase (9.90%) compared to females (9.50%). While Black/African American individuals initially had higher mortality rates, a significant surge in deaths among Non-Hispanic White individuals after 2013 (APC 10.42%) led to a convergence of mortality rates between the two groups by 2020. Geographically, the Midwest (APC 12.08%) and the South saw the most pronounced recent increases, whereas the West showed a sustained upward trend beginning as early as 2008. Conclusions: There has been a concerning reversal in ATIN-related mortality trends in the United States over the last decade. The convergence of racial mortality rates and significant regional variations suggest that shifting healthcare access, environmental factors, or medication exposure patterns (such as polypharmacy) warrant urgent investigation to mitigate this rising public health burden.